FY2029 Earnings Forecast for ACRV Issued By HC Wainwright
Acrivon Therapeutics, Inc. (NASDAQ:ACRV – Free Report) – Equities research analysts at HC Wainwright issued their FY2029 earnings estimates for Acrivon Therapeutics in a report issued on Wednesday, March 26th. HC Wainwright analyst E. Bodnar anticipates that the company will earn ($1.25) per share for the year. HC Wainwright has a “Buy” rating and a […]
Acrivon Therapeutics, Inc. (NASDAQ:ACRV – Free Report) – Equities research analysts at HC Wainwright issued their FY2029 earnings estimates for Acrivon Therapeutics in a report issued on Wednesday, March 26th. HC Wainwright analyst E. Bodnar anticipates that the company will earn ($1.25) per share for the year. HC Wainwright has a “Buy” rating and a […]
